Dr. Clyde Jones, MD

Expert Publications

• A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer.
• Proposed biosimilar pegfilgrastim (LA-EP2006) compared with reference pegfilgrastim in Asian patients with breast cancer: an exploratory comparison from two Phase III trials.

Media Releases

Get to know Hematologist-Oncologist Dr. Clyde Michael Jones, who serves patients in Tennessee.

Dr. Jones is a board-certified hematologist-oncologist who is affiliated with several Baptist Cancer Centers through the states of Mississippi and Tennessee, including Baptist Memorial Hospital-Union County (primary location), Baptist Memorial Hospital-Collierville, Baptist Memorial Hospital-DeSoto, Baptist Memorial Hospital-Memphis, Baptist Memorial Hospital-Tipton, Baptist Memorial Hospital for Women, and Baptist Memorial Restorative Care Hospital. 

Baptist Cancer Centers are located throughout the Mid-South so that patients can receive the advanced cancer care they need at a convenient location. From prevention to diagnosis through treatment and into survivorship, the cancer care team is there fighting and educating patients to help them beat cancer.

The doctor’s acclaimed career in medicine began after he earned his medical degree from the University of Alabama at Birmingham School of Medicine in 1974. He then went on to complete his internship at the University of Alabama in 1975, followed by his residency at the University of Alabama at Birmingham in 1976. Two years later, in 1978, he completed his fellowship at the Johns Hopkins University School of Medicine.

A Fellow of the American College of Physicians (FACP), Dr. Jones is board-certified in hematology and medical oncology by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Furthermore, he is licensed to practice medicine in several states throughout the United States, including Mississippi, Tennessee, Texas, Maryland, and Alabama.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of blood diseases and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia, and lymphoma. 

Recommended Articles

• Lymphoma, the Persistence of Inspirational Women, and the Power of Language

  Each year, Leukemia and Blood Cancer New Zealand (LBC) sponsors their Blood Cancer Patient Forum. They invite speakers to bring them news about such topics as treatment advances and management of cancer from a fully developed psycho-social perspective. Essentially, they dish up good old-fashioned...

• Living as a Hodgkin Lymphoma Survivor: Creating a New Normal

  No one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...

• The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer

  On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...

• Is Lymphoma-related PTSD Possible?

  PTSD is something that one may not think of right away when thinking of chronic or life-threatening illnesses, but it should not be overlooked. Post-traumatic stress disorder, or PTSD, can affect all aspects of a person’s life and requires treatment by a specialist.The Diagnostic and Statistical...

• Morphos Declared a "Breakthrough Therapy" for Lymphoma

  MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...

• Little Boy Tugs at Heartstrings of Entire Community: Be the Match!

  Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...